James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 9,000 shares at $1.77 ($16K) on 2019-06-20, disclosed to the SEC on 2019-06-21.
Open-market purchase of $16k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |